AMAS as a Cancer Test - Studies

Anti-malignin antibody in serum and other tumor marker determinations in breast cancer.

Thornthwaite JT.

Cancer Research Institute of West Tennessee, Henderson, TN 38340, USA.

In this study, 154 healthy volunteers and 76 patients were tested using the anti-malignin antibody in serum (AMAS) test. Of the 154 volunteers, three were AMAS positive. After further examination, two were positive for cancer and one had a history of ulcerative colitis.

Tumor biopsies of 43 suspicious mammography patients revealed that 32 were cancerous and 11 were benign by pathology. For the cancer patients, 31/32 were positive for the AMAS test, while 4/11 of the pathological benign cases were AMAS positive.

In comparison to cancer antigen tests, AMAS was more sensitive (97%) in detecting breast cancer than CEA (0%), CA 15-3 (10%), CA 19-5 (5%) or CA 125 (16%) in the same patients.

Cancer Lett. 2000 Jan 1;148(1):39-48.

AMAS - Possible Challenge to Cancer Management

Int J Biol Markers, 10-12/97

Early Detection & Monitoring with AMAS

Cancer Detect Prev, 1994

AMAS in Women Undergoing Biopsy

Cancer Epid Biomarkers & Prevention, 10/05

Remember we are NOT Doctors and have NO medical training.

This site is like an Encyclopedia - there are many pages, many links on many topics.

Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.